Dont miss to load up NUVB before Q-report on Monday! The short squeeze can be a fact! Insiders hold 19% of shares. CEO has 59M shares. Short interest 31% and they are gonna burn. Besides the earnings report Phase 2 Study on Safusidenib coming up this quarter. Ibtrozi is already in business with strong growth! This will pop to 15-20$ before Christmas🤶Thank me later 😎